Tenax Therapeutics (TENX) Posts Q2 Loss of 14c/Share

Tenax Therapeutics (NASDAQ: TENX) reported Q2 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
• StoneX Reiterates Hold Rating on Old Dominion Freight Line (ODFL) on QTD Operating Metrics